MENU
MDXG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

MiMedx Group (MDXG) Earnings Date & Reports

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

MDXG is expected to report earnings to fall 41.13% to 8 cents per share on March 04

MiMedx Group MDXG Stock Earnings Reports
Q4'25
Est.
$0.09
Q3'25
Beat
by $0.09
Q2'25
Beat
by $0.05
Q1'25
Est.
$0.06
Q4'24
Beat
by $0.01
The last earnings report on October 29 showed earnings per share of 15 cents, beating the estimate of 5 cents. With 979.80K shares outstanding, the current market capitalization sits at 1.11B.
View a ticker or compare two or three
MDXG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MDXG showed earnings on October 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of patent protected regenerative biomaterial products and bioimplants

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1775 West Oak Commons Court, NE
Phone
+1 770 651-9100
Employees
895
Web
https://www.mimedx.com